Related Experiment Video
Updated: Apr 27, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Ischemic stroke--diagnosis and treatment]
Insights
Promptly managing ischemic stroke involves limiting deficits and preventing recurrence. Current treatments include thrombolysis, antiplatelets, and supportive care, with secondary prevention tailored to stroke cause.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Emergency Medicine
Context:
- Ischemic stroke management requires a multi-faceted approach.
- Timely intervention is critical for improving patient outcomes.
- Established therapies and emerging strategies are continuously evaluated.
Purpose:
- To outline the key therapeutic objectives in ischemic stroke management.
- To review current evidence-based treatments for acute ischemic stroke.
- To discuss strategies for preventing early recurrence and long-term complications.
Summary:
- Intravenous thrombolysis within 4.5 hours of stroke onset is the only proven therapy to improve functional outcomes.
- Early administration of antiplatelet agents (e.g., aspirin, clopidogrel) prevents stroke recurrence, while anticoagulants are contraindicated due to hemorrhage risk.
- Supportive measures like heparin, mobilization, and decompressive craniectomy address complications such as venous thromboembolism, pneumonia, and brain edema.
- Secondary prevention strategies are etiology-dependent, including anticoagulation for atrial fibrillation and endarterectomy for carotid stenosis.
Impact:
- Provides a concise overview of current ischemic stroke management guidelines.
- Highlights the importance of timely and appropriate therapeutic interventions.
- Informs clinical decision-making for healthcare professionals treating stroke patients.
Abstract:
Management of ischemic stroke is targeted on four therapeutic objectives: limitation of neurological deficit, prevention of earyl stroke recurrence, protection against complications, and secondary prevention. Intravenous thrombolysis within 4.5h of stroke onset is the only proven therapy to improvefunctional outcome. Although promising, neither endovascular recanalisation nor neuroprotective strategies have demonstrated efficacy so far. Immediate administration of antiplatelet agents like acetylsalicylic acid and clopidogrel - in case of intravenous thrombolysis at the earliest after 24h - is effective to prevent early stroke recurrence, whereas anticoagulants should be ommitted in this stage because of an increased risk of cerebral hemorrhage. Subcutaneous heparin/low molecular weight heparin, mobilisation, nasogastric tube, and decompressive craniectomy may protect from venous thromboembolism, aspiration pneumonia, and malignant brain edema, respectively. Secondary prevention is guided by stroke etiology, e.g. oral anticoagulation in the presence atrial fibrillation or endarterectomy in case of sympomatic high-grade carotid stenosis.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Stroke: Introduction and Types
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

